Furthermore, the loss of HIRA activates MYC and its target genes, independent of its chaperone activity, and enhances the proliferation and invasion of fumarate hydratase deficient hereditary leiomyomatosis and renal cell carcinoma (HLRCC)153. The gene discussed is HIRA; the disease is hereditary leiomyomatosis and renal cell cancer.